How to Build an Unbranded Disease Education Page That Ranks in AI Search

Why Unbranded Disease Education Is the Most Valuable Pharma Content Asset Right Now

Something significant has shifted in how patients and healthcare professionals find medical information. They no longer type two keywords into Google and click the first blue link. They ask ChatGPT, Perplexity, or Google Gemini a full question and they expect a complete, sourced, synthesized answer in return.

This changes everything for pharma content strategy. And it changes it in a direction that dramatically favours one specific content format: unbranded disease education.

Here is why. AI systems, whether they operate via retrieval-augmented generation (RAG) or training-encoded knowledge, are built to surface content that is factual, clearly attributed, medically accurate, and free of promotional intent. Branded content, by design, is partial: it advocates for a specific product. Unbranded disease education, by design, is neutral, comprehensive, and educational. It is structurally closer to what AI systems are trained to trust and cite.

At the same time, the regulatory landscape strongly incentivises this format. According to FDA guidelines, fair balance requirements — the obligation to present risk information proportionate to benefit claims — do not apply to disease awareness content that does not name a specific drug. However, they still must not be false or misleading, and they cannot indirectly promote a specific product in a way that would reclassify them as drug advertising.¹ In Europe, EFPIA guidance holds companies responsible for all content disseminated via digital channels when initiated or sponsored by the company,² but disease education content that meets factual, non-promotional standards operates in significantly more permissive territory than branded promotion.

The result: a well-built unbranded disease education page is simultaneously your most compliant content, your fastest-to-approve content, if built correctly, your most likely content to be cited in AI-generated answers and the best way to support patients all along their journey.

What “Ranking in AI Search” Actually Means for a Disease Education Page

Before describing the build process, it is worth being precise about what AI visibility means — because it is different from traditional SEO ranking.

In traditional search, a page “ranks” when it appears high in a list of results. A user chooses to click.

In AI search, a page “surfaces” when an LLM uses it as a source to construct an answer. The user never sees a ranked list — they see a synthesised response. If your content contributed to that response, it may be cited; if not, it is invisible regardless of how well it ranks on Google.

What drives AI citation is not primarily keyword optimisation. It is a combination of:

• Entity clarity: the AI can unambiguously identify what the page is about (a specific condition, a specific symptom cluster, a specific patient population).
• Factual density: the page contains specific, verifiable claims — statistics, mechanisms, diagnostic criteria — that an AI can extract and use.
• Source authority: the content is attributed to credentialed authors, reviewed by medical experts, and linked to recognised external sources (clinical guidelines, peer-reviewed publications, regulatory bodies).
• Structural extractability: the content is organised so that an AI can identify discrete answers to discrete questions — not buried in long narrative prose.
• Machine-readability: schema.org markup connects the page’s entities to a broader knowledge graph that AI systems consult.

A disease education page built to these standards does not just help patients. It positions your organisation as a citable source inside AI-generated answers on the conditions you treat.

Step 1: Choose the Right Disease and Angle

Not all diseases offer equal AI search opportunity. The best candidates share a specific combination of characteristics.

High AI search opportunity exists when:

• Diagnosis is delayed or missed. Conditions with long diagnostic odysseys — rare diseases, autoimmune conditions, neurological disorders — generate substantial patient search activity precisely because conventional information sources have failed them. These patients are highly likely to use AI tools for answers.
• Patient-physician conversation is a bottleneck. In therapeutic areas where patients are often undiagnosed or undertreated, unbranded education that helps patients recognise symptoms and initiate a conversation with their doctor has measurable downstream value.
• The online information landscape is thin or poor quality. In disease areas dominated by academic jargon or outdated content, a well-structured, plain-language education page can establish authority quickly.
• Your organisation has genuine scientific depth. AI systems do not just surface any content — they favour content that demonstrates expert knowledge. If your medical affairs or clinical teams have meaningful expertise in a condition, that expertise should anchor the content.

Conduct a three-point opportunity assessment before committing to a topic:

Practical rule: the best disease education topic is one where a patient or HCP could ask an AI tool a reasonable question about the condition and receive a poor or incomplete answer. Your page exists to fix that gap.

Step 2: Define Your Audience and Their Exact Questions

A disease education page is not a general resource for everyone. It serves a specific audience with specific information needs at a specific moment in their journey.

Before writing a single word, define:

Who is the primary audience?

• A patient recently diagnosed who needs to understand what the condition means for their daily life?
• A patient who suspects they have the condition and is seeking symptom recognition?
• A caregiver supporting a family member?

What are the five to seven most urgent questions this audience is actually asking?

Do not guess. Use the following sources to identify real questions:

• Run the condition name in Perplexity and examine what the AI answers — these are the questions being asked.
• Check the “People Also Ask” section on Google for the condition name.
• Review patient forum threads (PatientsLikeMe, Reddit condition-specific communities) for the language patients use.
• If you have medical affairs contacts, ask what questions HCPs most commonly ask about diagnosis or patient identification.

These questions become the H2 structure of your page. They are also the questions that AI systems will attempt to answer when users search for the condition — and your page should answer each one clearly and directly.

Step 3: Define the Regulatory Perimeter Before Writing

This step must happen before drafting, not after. It defines what the page can and cannot contain.

The unbranded rule: the page must not name any specific drug, brand, or your company’s product portfolio. It may describe treatment modalities (e.g., “monoclonal antibodies,” “JAK inhibitors,” “disease-modifying therapies”) at a class level, if relevant to the condition and not structured to imply a specific product.¹

The non-promotional rule: the page must be genuinely educational. Content that uses disease language to guide readers toward a specific treatment, that presents the condition’s natural history in a way that is only relevant if a specific drug is available, or that mirrors the visual identity or messaging of a branded campaign may be treated as promotional by the FDA, even if it does not name a drug.³

The sponsorship transparency rule: if the page is company-funded, it should be clearly identified as such. This is both an FTC requirement for sponsored content and an E-E-A-T signal — users and AI systems trust content that is transparent about its source.⁴

The EFPIA/IFPMA consideration (EU context): in European markets, companies are responsible for all content they initiate or sponsor via digital channels.² This means the unbranded disease education page, even if published on a standalone site without your company name, is subject to the same governance process as branded content if your company is the initiating sponsor.

The compliance checkpoint: before drafting, document the following in a one-page regulatory brief that accompanies the content into MLR review:

• Condition covered
• Target audience
• Drugs or treatment classes referenced (or explicitly not referenced)
• Sponsorship and attribution approach
• Jurisdictions where the page will be published
• MLR reviewer names and sign-off process

Critical reminder: this article provides informational guidance on content strategy, not legal or regulatory advice. All disease education content must go through your organisation’s Medical, Legal, and Regulatory (MLR) review and approval process before publication. Compliance responsibility rests with your organisation.

Step 4: Build the Page Architecture

A disease education page that ranks in AI search needs a specific architecture. This is not a blog post and it is not a brochure. It is a structured knowledge resource.

The recommended page structure:

Section 1: Condition Definition (What is [condition]?)

A precise, clinically grounded definition of the condition. Two to three sentences. Written for the primary audience’s reading level. This is the section most likely to be extracted verbatim by AI systems. Make it exact and citable.

Section 2: Epidemiology (Who does [condition] affect?)

Prevalence, incidence, affected populations, geographic distribution if relevant. Always cite the source (clinical guideline, peer-reviewed publication, registry data). Specific numbers are far more likely to be cited by AI than general descriptions.

Section 3: Symptoms and Signs (What are the symptoms of [condition]?)

A structured list or table. For complex conditions, separate early symptoms from advanced presentations, or patient-reported symptoms from clinically observed signs. Structured formats are significantly more extractable by AI systems than narrative paragraphs.

Section 4: Diagnosis (How is [condition] diagnosed?)

Diagnostic criteria, recommended investigations, and — critically for AI citation — the source of those criteria (e.g., DSM-5, ACR/EULAR guidelines, published consensus criteria). Link to the original guideline document.

Section 5: Treatment Overview (How is [condition] treated?)

Treatment modalities at a class level. This section requires the most careful MLR review. Describe the evidence base for treatment approaches without naming specific agents. If the condition has an approved treatment landscape, describe the mechanism classes and the goals of therapy.

Section 6: Living With [Condition] (Patient experience)

Functional impact, quality-of-life considerations, patient support resources. This section builds trust with patient audiences and is highly valued by AI systems because it addresses search queries that go beyond the clinical.

Section 7: Key Questions to Ask Your Doctor

A structured list of questions that help patients initiate or deepen a conversation with their healthcare provider. This is both genuinely useful and strategically valuable — it positions the page as a patient empowerment resource rather than a promotional one.

Section 8: FAQPage (Structured Q&A)

A dedicated FAQ section with five to ten questions and concise, direct answers. This is the highest-impact section for AI extractability. FAQPage schema markup applied to this section makes each question-answer pair directly machine-readable.

Read: https://oliviergryson.com/pharma-geo-building-knowledge-graphs-that-ai-systems-trust/

Step 5 — Write for Both Human Readers and AI Extractability

The writing principles for AI-optimised disease education content are not fundamentally different from good medical writing. But there are specific techniques that significantly improve AI citation likelihood.

Use the PICO structure for clinical claims

Every clinical claim should be grounded in Population, Intervention, Comparator, Outcome — the framework used in evidence-based medicine to describe the basis of a finding. When an AI system encounters a claim in PICO format, it can extract and attribute it with high precision.

Instead of this: “Treatment improves outcomes in patients with the condition.”

Write this: “In adults with moderate-to-severe [condition] who had inadequate response to conventional therapy, [treatment class] demonstrated a significant reduction in [outcome measure] compared to placebo (Source: [citation]).”

The second version is citable. The first is not.

Name entities consistently

Use the condition’s exact medical name (and its ICD-10 code where appropriate) consistently throughout the page. Avoid alternating between the full name, acronyms, and colloquial terms within the same page — this creates ambiguity that reduces AI extraction accuracy.

Write short, declarative sentences for key facts

AI systems extract claims more reliably from short, declarative sentences than from complex subordinate clause structures. For facts you want cited, write them as standalone sentences.

Cite primary sources, not secondary ones

Link directly to the peer-reviewed study, the clinical guideline, or the regulatory document — not to another website that summarises it. AI systems assess source authority through the chain of citations. A link to the original NEJM paper signals authority; a link to a health portal that summarised it does not.

Use plain language for patient-facing sections

Where the primary audience includes patients, plain language is not a stylistic choice — it is an E-E-A-T requirement. Google’s quality rater guidelines specify that health content should be written at an appropriate reading level for its target audience.⁵ AI systems trained on these quality signals will favour content that is simultaneously accurate and accessible.

Step 6 — Build the E-E-A-T Architecture

Disease education content is classified as YMYL (Your Money or Your Life) content by Google’s quality systems.⁵ This means it is subject to the most rigorous quality standards in the search ecosystem. As of the January 2025 and September 2025 updates to Google’s Search Quality Rater Guidelines, these standards have become more demanding, not less.⁶

For a disease education page, E-E-A-T must be demonstrated explicitly — not assumed.

Experience

The author or contributor should have direct clinical or patient experience with the condition. A page authored by a medical affairs physician, co-authored with a patient advocacy organisation, or reviewed by a treating specialist demonstrates experience in a way that a generic “health writer” cannot.

Read: https://oliviergryson.com/e-e-a-t-pharma-experience-hcp-content-tips/

Expertise

Every page must have a named author with verifiable credentials. The author bio should include:

• Full name and professional title
• Medical or scientific qualifications (degree, specialty certification)
• Institutional affiliation
• ORCID iD if the author has a research publication record
• A link to a verifiable external profile (institutional page, LinkedIn, ORCID)

Read: https://oliviergryson.com/eeat-expertise-pharma-hcp-conten-tips/

Authoritativeness

Authority for a disease education page is established through:

• Citation of recognised clinical guidelines (ACC/AHA, NICE, ACR, ESMO, etc.)
• Reference to peer-reviewed literature (PubMed-indexed publications)
• Links to authoritative third-party resources (WHO, CDC, NIH, EMA)
• Endorsement or co-authorship from recognised patient advocacy organisations or medical societies

Read: https://oliviergryson.com/eeat-authoritativeness-pharma-hcp-content/

Trustworthiness

Trust signals that must be present on every disease education page:

• Clear identification of the organisation responsible for the content
• Disclosure of any company sponsorship (even if the page appears on a standalone disease education site)
• A visible last-reviewed date
• A content disclaimer specifying that the page is for educational purposes and does not constitute medical advice
• A process for users to report inaccurate content (contact link or feedback mechanism)

Read: https://oliviergryson.com/trustworthiness-pharma-hcp-content/

Step 7 — Implement Schema.org Markup

Schema.org markup is the technical layer that connects your disease education page to the knowledge graphs that AI systems consult⁷. Without it, your content is human-readable but partially machine-opaque. With it, your content is both.

Read: https://oliviergryson.com/pharma-geo-building-knowledge-graphs-that-ai-systems-trust/

For a disease education page, implement the following schema types, nested as a single JSON-LD block.

(Note that if your website is powered with WordPress, some plugins like Yoast or Schema & Structured Data for WP & AMP massively facilitate the creation of Schema markups), and do not require to dive into json files.

MedicalWebPage (wrapper)

This tells search engines and AI systems that the page is specifically a medical information resource, not a general article.

json

{
  "@context": "https://schema.org",
  "@type": "MedicalWebPage",
  "name": "[Page Title]",
  "url": "https://your-domain.com/disease-education/[condition]",
  "datePublished": "YYYY-MM-DD",
  "dateModified": "YYYY-MM-DD",
  "lastReviewed": "YYYY-MM-DD",
  "reviewedBy": {
    "@type": "Person",
    "name": "[Reviewer Name]",
    "jobTitle": "[Medical Title, e.g. Consultant Rheumatologist]",
    "affiliation": {
      "@type": "MedicalOrganization",
      "name": "[Institution Name]"
    }
  },
  "audience": {
    "@type": "MedicalAudience",
    "audienceType": "Patient"
  },
  "specialty": {
    "@type": "MedicalSpecialty",
    "name": "[Relevant Medical Specialty]"
  },
  "about": {
    "@type": "MedicalCondition",
    "name": "[Condition Full Name]",
    "alternateName": "[Condition Abbreviation or Common Name]",
    "code": {
      "@type": "MedicalCode",
      "code": "[ICD-10 Code]",
      "codingSystem": "ICD-10"
    },
    "associatedAnatomy": {
      "@type": "AnatomicalStructure",
      "name": "[Relevant Anatomy]"
    },
    "possibleTreatment": {
      "@type": "MedicalTherapy",
      "name": "[Treatment modality at class level — not a specific drug name]"
    },
    "signOrSymptom": [
      { "@type": "MedicalSymptom", "name": "[Symptom 1]" },
      { "@type": "MedicalSymptom", "name": "[Symptom 2]" }
    ]
  },
  "author": {
    "@type": "Person",
    "name": "[Author Name]",
    "jobTitle": "[Title]",
    "sameAs": [
      "https://orcid.org/[ORCID-iD]",
      "https://www.wikidata.org/wiki/[Q-ID if applicable]"
    ]
  },
  "publisher": {
    "@type": "Organization",
    "name": "[Publishing Organisation]",
    "url": "https://your-domain.com"
  }
}

FAQPage (for the Q&A section)

Add this as a second JSON-LD block on the same page. Each FAQ entry is a direct signal to AI systems that this question-answer pair is extractable.

Again, WordPress plugins allow to generate these files without typing any line of code.

json

{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is [condition]?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "[Concise, direct answer — 2 to 4 sentences maximum]"
      }
    },
    {
      "@type": "Question",
      "name": "What are the symptoms of [condition]?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "[Structured symptom list]"
      }
    }
  ]
}

Validation: After implementation, validate both blocks at validator.schema.org and search.google.com/test/rich-results. Fix any errors before publication.

Note that this phase is pretty technical. I recommend you to simply ensure from your digital team that they implemented it.

Compliance note: Schema markup must accurately represent the page it annotates. Marking a disease education page as if it were a peer-reviewed article, or attributing it to a reviewer who did not actually review it, violates both Google’s structured data policies and basic content integrity standards. And future regulations may decide to sanction it. Let’s anticipate and structure content correctly and ethically.

Step 8: Internal Linking and Topical Authority

A single disease education page will not establish topical authority on its own. AI systems, and Google’s quality algorithms, assess authority at the domain level as well as the page level. A page on an isolated domain with no related content is less authoritative than a page that sits within a structured content hub.

Build a minimum viable content hub around each disease education page:

All pages in the hub should link to each other using descriptive anchor text that mirrors the entity names used in schema markup. This creates a machine-readable content graph — not just a collection of separate pages.

Step 9: Monitor AI Visibility After Publication

The final step is not a launch activity — it is an ongoing programme. AI citation is dynamic: new content enters AI systems through training updates and RAG index refreshes. Your page’s citation status can change without your organic rankings changing at all.

Build a monthly monitoring routine:

1. Define your query set. Identify fifty other hundreds of questions that patients or HCPs would realistically ask about the condition. These should cover: definition, symptoms, diagnosis, treatment modality, prognosis, and patient support. Include both plain-language patient queries and clinical-language HCP queries.
2. Run queries across all major AI systems. Test ChatGPT (GPT-4 and above), Perplexity AI, Google AI Overviews, and Microsoft Copilot. Document whether your page is cited, whether your page’s content is reproduced without citation, and whether competitor or third-party content is cited instead.
3. Score your citation rate. Calculate the percentage of queries for which your page is cited across all four platforms. Track this monthly. A rising citation rate is the primary KPI for AI search visibility.
4. Diagnose gaps. When your page is not cited despite covering the relevant content, the cause is usually one of the following:
   • Missing or incorrect schema markup
   • Author attribution missing or unverifiable (no ORCID, no external profile)
   • Content too general — no specific, extractable facts
   • Competitor page has stronger entity linkage (Wikidata entries, more citations)
   • Page is too new — AI training updates have not incorporated it yet
5. Update on a defined schedule. Set a minimum six-month content review cycle. Disease education pages go stale: guidelines update, new epidemiological data emerges, standard of care shifts. Stale content is penalised by Google’s freshness signals and under-trusted by AI systems.

Complete Build Checklist

Use this checklist as the sign-off document before submitting the page for MLR review and publication.

Strategic foundation

•  Topic selected based on AI search opportunity assessment (ChatGPT, Perplexity, Google AI Overviews audit completed)
•  Primary audience defined
•  Five to seven priority questions identified from real patient/HCP query data
•  Regulatory perimeter documented and reviewed (condition, drug/class references, jurisdictions)

Content quality

•  Condition defined precisely using exact medical terminology and ICD-10 code
•  All clinical claims in PICO format with primary source citations
•  Symptoms presented in structured format (table or numbered list)
•  Diagnosis section references specific clinical guidelines (with links to originals)
•  Treatment section stays at class level — no drug names
•  Patient experience section present (quality of life, day-to-day impact)
•  “Questions to ask your doctor” section present
•  FAQ section with five to ten question-answer pairs, each answerable in two to four sentences
•  Plain language used for patient-facing sections (target: grade 8 reading level)
•  All statistics sourced to peer-reviewed publications or recognised registries

E-E-A-T signals

•  Named author with full credentials and verifiable external profile
•  Medical reviewer named with specialty, institution, and review date
•  ORCID iD displayed for author (if applicable)
•  Sponsorship/company affiliation clearly disclosed
•  Content disclaimer present (“for educational purposes only; not medical advice”)
•  Last-reviewed date visible on page
•  Links to authoritative external resources (clinical guidelines, patient advocacy organisations)

Technical implementation

•  MedicalWebPage JSON-LD implemented and validated
•  MedicalCondition properties completed (code, symptoms, anatomy, treatment modality)
•  FAQPage JSON-LD implemented and validated
•  Author sameAs linking to ORCID and/or Wikidata
•  Validated at validator.schema.org (zero errors)
•  Internal links to related hub content in place
•  Page URL uses condition name (not drug name or brand term)
•  Meta description summarises the page’s educational purpose and target audience

Compliance and governance

•  MLR review completed and documented
•  Regulatory brief attached to MLR submission
•  Jurisdiction-specific requirements reviewed (FDA for US; EFPIA/national codes for EU)
•  Monitoring schedule established (query set defined, review cycle set)

Key Takeaways

Unbranded disease education is structurally aligned with what AI systems trust. Neutral, factual, expert-attributed content is exactly what LLMs are designed to surface. Branded content, by design, is not. It supports patients all along their journey.

Topic selection is a strategic decision, not a content decision. The best disease education pages address conditions where the information gap is real, the diagnostic journey is long, and your organisation has genuine scientific depth. This should be driven by Marketing functions, not technical ones.

E-E-A-T is not a checklist item. It is the foundation. AI systems and Google’s quality algorithms both evaluate author authority, source credibility, and content accuracy. Disease education content that cannot demonstrate these signals will not be cited, regardless of how well it is written.

Schema markup connects your page to the knowledge graph. MedicalWebPage and FAQPage structured data are not optional technical enhancements. They are the machine-readable layer that allows AI systems to extract, attribute, and cite your content with precision.

AI visibility is a continuous programme. A page published once and left static will lose citation share as the information environment evolves. Build a monitoring and refresh cycle from launch.

References

1. Consumer-Directed Broadcast Advertisements, US FDA, Last accessed 30/05/2026 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/consumer-directed-broadcast-advertisements.

2. EFPIA code of practice https://www.ifpma.org/wp-content/uploads/2022/12/230220-EFPIA-Code.pdf Last accessed 30/05/2026

3. Draft Guidance for Industry Help Seeking and Other Disease Awareness Communications by or on Behalf of Drug and Device Firms https://www.regulations.gov/document/FDA-2004-D-0500-0002 Last accessed 30/05/2026

4. Guides concerning use of endorsements and testimonials in advertising. https://www.ecfr.gov/current/title-16/chapter-I/subchapter-B/part-255/section-255.0 Last accessed 30/05/2026

5. Google. (2025). Creating Helpful, Reliable, People-First Content. Google Search Central. https://developers.google.com/search/docs/fundamentals/creating-helpful-content Last accessed 30/05/2026

6. StanVentures. (2025). Google Updates Quality Rater Guidelines: AI & YMYL. Retrieved from https://www.stanventures.com/news/google-updates-search-quality-raters-guidelines-ai-overviews-clearer-ymyl-definitions-4360/ Last accessed 30/05/2026

7. Schema.org. Health and Medical Types.  https://schema.org/docs/meddocs.html Last accessed 30/05/2026

Olivier Gryson, PharmD, MSc
25 years of experience in digital marketing in the pharmaceutical industry
Special focus on AI Search in Pharma Marketing